Placeholder Banner

BIO files Amicus Brief in Colorado PDAB Case

September 13, 2024

The Biotechnology Innovation Organization (“BIO”) respectfully moves the Court for leave to file an amicus brief in support of Plaintiffs’ response in opposition to the Defendants’ cross-motion for summary judgment. Copies of the proposed brief and proposed order are attached. Counsel for BIO has conferred with counsel for all parties: while counsel for Plaintiffs do not oppose this motion for leave to file an amicus brief, counsel for Defendants represented that Defendants oppose the motion.

Related Resources
BIO files Amicus Brief in Colorado PDAB case
Discover More
BIO filed an amicus brief in the Supreme Court of the State of California, encouraging its review of the lower court decision in the Gilead Tenofovir Cases.The Court of Appeal decision operates from a misunderstanding of the drug development and FDA…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
BIO filed an amicus brief in a continuing effort to challenge courts' decisions that undermine FDA authority and hinder patient access to medications.The brief was filed in the Supreme Court of the United States (SCOTUS), following the August 2023…